Is there a blood test for CTE? What a new 2026 study found

Reviewed November 2026 by Online Concussion Clinic, a Perth-based telehealth concussion physiotherapy service. How this site is run

Beyond the clinic: research update

Short answer

Not yet. A study published in JAMA in November 2026 found that a blood marker called eMTBR-tau243 was raised in people with advanced chronic traumatic encephalopathy (CTE) compared with healthy people. It couldn't reliably detect early CTE or tell CTE apart from Alzheimer's disease on its own, so it isn't a test you can get, but it's a step toward diagnosing CTE in living people.

What is CTE?

Chronic traumatic encephalopathy (CTE) is a brain disease linked to years of repeated head impacts, such as in contact sport or military service. Over time, an abnormal protein called tau builds up in the brain. At the moment, CTE can only be confirmed by examining the brain after death, which is why a test for living people would be such a big step.

For more on what CTE is, its symptoms and the Australian research, read can concussion cause CTE?

A concussion is not CTE. CTE is linked with repeated head impacts over many years, not a single concussion, and most people recover from a concussion within weeks. Managing every concussion properly and avoiding further knocks while you recover is still the best way to protect your brain.

What the study did

  • Who: researchers at Washington University School of Medicine in St. Louis and the University of California, San Francisco.
  • Participants: 229 people from several brain banks and research cohorts, including people whose brain disease was confirmed after death and healthy volunteers. The blood testing included 11 people with CTE confirmed at autopsy.
  • What they measured: eMTBR-tau243, a fragment of the tau protein, measured in blood with a highly sensitive laboratory method (mass spectrometry).
  • Why this marker: CTE and Alzheimer’s disease both build up a mixture of two forms of tau (called 3-repeat and 4-repeat). Some other brain diseases build up only one. This marker appears to track the mixed type.

What they found

  • Advanced CTE: blood levels were higher than in healthy people, and the test separated advanced CTE from healthy people with high accuracy.
  • Levels rose with severity: people with more advanced CTE had higher levels.
  • Alzheimer’s disease: levels were very high, and much higher than in CTE.
  • Single-tau diseases: levels were low.
  • Early CTE: the test couldn’t reliably detect it.

eMTBR-tau243 in blood: how the groups compared (relative →)

Alzheimer’s disease had very high levels. Advanced CTE had raised levels, higher than healthy people but much lower than Alzheimer’s. Early CTE could not be reliably told apart from healthy people. Healthy people and diseases with only one type of tau had low levels.

Bar lengths show the relative pattern the researchers described — they are an illustration, not measured values, which weren’t included in the published summaries. *Diseases with only one type of tau, such as progressive supranuclear palsy, corticobasal degeneration and Pick’s disease.
Blood levels rose with CTE stage Levels in stage I CTE were significantly lower than in stage IV. Stage III appeared to fall in between, based on only two brains. Stage I Stage III Stage IV Lower In between Highest More advanced CTE → higher blood level
Levels rose with disease stage. Stage I was significantly lower than stage IV. Stage III appeared to fall in between, but only two stage III brains were available. Positions are illustrative.

What it can’t do yet

  • It isn’t available as a test for CTE. It hasn’t been validated for diagnosing CTE.
  • It misses early disease, when a diagnosis would matter most.
  • It can’t work alone. Because the marker is also high in Alzheimer’s disease, which often occurs alongside CTE, it would need to be combined with a test that rules out Alzheimer’s. As one of the lead researchers put it, “This is not going to be a standalone biomarker.”
  • It was a small study — only 11 people with CTE. Larger studies are needed.

Critical appraisal

Strengths

  • Direct biochemical measurement of the marker in blood
  • Diagnoses confirmed by examining the brain after death (neuropathology) in the relevant groups
  • Comparisons across several different neurodegenerative conditions, not just CTE versus healthy people

Limitations

  • The CTE group was extremely small — only 11 cases.
  • Samples came from brain banks and research cohorts, which may not reflect the full range of people seen in clinics (spectrum bias).
  • The time between blood collection and autopsy complicates interpretation.
  • The study didn’t test a diagnostic cut-off in living people presenting with suspected CTE.

Evidence assessment

Very low certainty for routine clinical diagnosis of CTE, despite promising biological findings.

Clinical implications

This is potentially important for the long-term development of biomarkers, but there is still no validated blood test for diagnosing CTE in routine clinical practice.

A former contact-sport athlete with memory or thinking concerns should not be labelled as having CTE because of their concussion history, their symptoms, or an experimental biomarker. A careful assessment for other causes, a mental health assessment, a sleep evaluation and appropriate neurological referral remain essential.

Why it matters for Australian football

CTE isn’t just an NFL story. Graham “Polly” Farmer, the WA football great, was the first Australian rules footballer confirmed with CTE, by the Australian Sports Brain Bank. A blood test that could identify CTE in living people would help former players get answers sooner, and help researchers test treatments.

For now, the most important steps are the ones in your control: take every concussion seriously, follow your sport’s return-to-play rules, and don’t return while you still have symptoms. See concussion rules for Australian football and rules for other sports.

Worried about your brain health after years of head knocks?

If you’ve noticed changes in memory, mood, behaviour or concentration, start with your GP. They can look for treatable causes and refer you to a neurologist or other specialist if needed. If you’ve had a recent concussion, a concussion-trained health professional can guide your recovery.

Find concussion care in Perth

Browse verified concussion providers across Perth — physiotherapists, GPs and neuropsychologists — and use the map to find one close to home. You don't need a referral to see a physiotherapist privately.

Where this information comes from

  • Horie K, Koppisetti RK, VandeVrede L, et al. Fluid eMTBR-tau243 as a biomarker of 3-repeat/4-repeat mixed tau pathology. JAMA. Published 13 November 2026. doi:10.1001/jama.2026.24689. doi.org
  • Washington University School of Medicine in St. Louis. Progress toward a blood test for CTE (news release, November 2026). medicine.washu.edu
  • The New Daily. Graham ‘Polly’ Farmer first Australian rules footballer diagnosed with CTE (2020). thenewdaily.com.au
  • Australian Institute of Sport. Concussion and Brain Health Position Statement 2024. ausport.gov.au/concussion

Summary written November 2026 from the published study details and the researchers’ official summary. The technology has been licensed to C2N Diagnostics, and some authors may receive income from that licence. This page is general information, not medical advice.

More concussion information

Concussion rules by sport · Common concussion questions